Mayo Clinic December 16, 2021
Personalized nutrition therapy that takes into account one’s genotype has tremendous promise, but the evidence supporting its use in routine patient care is mixed.
By John Halamka, M.D., president, Mayo Clinic Platform, and Paul Cerrato, MA, senior research analyst and communications specialist, Mayo Clinic Platform
On the wish list of many clinicians and patients is a precise blueprint that tells individuals their predisposition to specific diseases, their unique biochemical profile, as well as their requirements for physical activity, nutrients, and much more. While we are a long way off from having such blueprints, we are slowly approaching this ideal personalized medicine scenario. Nutrigenomics is one such area that offers promise. But a closer look at the specialty demonstrates the...
Today's Sponsors
Today's Sponsor